Edward T. Wei
41Patents
10h-index
15Co-inventors
72Inventor score
Filing activity: Mar 30, 1983 → Sep 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4801612A | Method of inhibiting inflammatory response | Human Necessities | 28 | Expired |
| US5480869A | Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues | Human Necessities | 26 | Expired |
| US5869450A | Anti-inflammatory compositions and method with corticotropin-releasing factor analogs | Human Necessities | 21 | Expired |
| US6205486A | Inter-network bridge connector provided for dynamically prioritizing frame transmission adaptive to current network transmission-state | Electricity | 20 | Expired |
| US5137871A | Treatment to reduce edema for brain and musculature injuries | Human Necessities | 18 | Expired |
| US6919348B2 | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | Human Necessities | 18 | Expired |
| US6228840A | Melanocortin receptor antagonists and modulations of melanocortin receptor activity | Human Necessities | 16 | Expired |
| US5177060A | Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues | Human Necessities | 15 | Expired |
| US5482930A | Anti-inflammatory composition and method with des-Tyr dynorphin and analogues | Human Necessities | 13 | Expired |
| US4481191A | Method for controlling blood pressure | Human Necessities | 10 | Expired |
| US9642868B2 | Topical agents for the treatment of sensory discomfort in the nasal cavity | Human Necessities | 9 | Active |
| US9956232B2 | Dialkyl-phosphinoyl-alkane (Dapa) compounds and compositions for treatment of lower gastrointestinal tract disorders | Human Necessities | 6 | Active |
| US10195217B2 | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort | Chemistry; Metallurgy | 6 | Active |
| US9895382B2 | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort | Physics | 6 | Active |
| US5306710A | Method for treating endotoxin shock with CRF | Human Necessities | 6 | Expired |
| US10722477B2 | Cooling adjunct for medications to treat disorders in the nasal cavity | Human Necessities | 6 | Active |
| US6319900A | Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs | Human Necessities | 4 | Expired |
| US5488033A | Treatment to reduce edema | Human Necessities | 4 | Expired |
| US6893626B2 | Compositions for TRP-M8 binding and radioreceptor methods therewith | Chemistry; Metallurgy | 4 | Expired |
| US6953779B2 | Melanocortin receptor antagonists and modulations of melanocortin receptor activity | Human Necessities | 3 | Expired |
| US11406649B2 | Treatment of upper aerodigestive tract disorders and cough | Human Necessities | 3 | Active |
| US11389397B2 | Method to reduce face mask and respirator discomfort | Human Necessities | 3 | Active |
| US8529915B2 | (R)-(-)-1,2-propanediol compositions and methods | Human Necessities | 3 | Active |
| US5374621A | Neurotensin method for inhibiting vascular leakage | Human Necessities | 3 | Expired |
| US11389462B2 | Method to reduce face mask and respirator discomfort | Human Necessities | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.